NCT03676439

Brief Summary

Lateral cord stimulation (LCS) was discovered by the author as the producer of an average threshold increase for abnormal muscle contraction responses, in experimental pathological conditions, as described and referred. This physiological effect is proposed to improve tone, motor function and speech, in patients with spasticity of different causes, such as cerebrovascular accident, congenital brain malformations, perinatal anoxia (image called cerebral palsy), sequels of neurosurgery, etc. Due to its non-invasiveness and possible efficacy, the use of magnetic stimulation is proposed to try to demonstrate its therapeutic utility. This is the clinical test of phase 2/3 of the method, in the future, and how its use could be extended, if the results were positive, its indications could be extended to other pathological conditions, giving a greater spectrum of spastic patients, potentially benefited

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Nov 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 18, 2018

Completed
6.2 years until next milestone

Study Start

First participant enrolled

November 18, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2026

Completed
Last Updated

November 21, 2023

Status Verified

November 1, 2023

Enrollment Period

12 months

First QC Date

September 4, 2018

Last Update Submit

November 20, 2023

Conditions

Keywords

Lateral Cord StimulationDisabilityMagnetic StimulationSpasticitySpinal Cord Stimulation

Outcome Measures

Primary Outcomes (2)

  • Changes in Modified Ashworth Scale (MAS)

    Scale evaluationg muscle stiffness, from 0(normal) to 5 (maximal rigidity). It wiil be employed to evaluate the spasticity related to limbs.

    One pre interventional and monthly - up to three months - post interventional

  • Changes in Functional Independence measure (FIM) for the speech.

    The FIM measures what an individual can perform - Only the ability for communication, comprehension and expression, will be evaluated to assess speech changes

    One pre interventional and monthly - up to three months - post interventional

Secondary Outcomes (1)

  • Changes in Barthel's Scale

    One pre interventional and monthly - up to three months - post interventional

Study Arms (2)

Treated Arm: Magnetic Spinal Stimulation plus PKT

ACTIVE COMPARATOR

Three months of kinesthetic and phoniatric treatment, and Magnetic Spinal Stimulation, 80% of the cervical muscles's motor threshold, 100 pulses at 10Hz, lasting 10 seconds, repeated during 30 minutes, twice a week for 3 months on cervical lateral location, focalized on the Lateral Spinal Cord.

Device: Magnetic Spinal Stimulation

Sham comparator

PLACEBO COMPARATOR

They will receive kinesthetic and phoniatric treatment, and during 3 months,with equal periodicity, they will receive a sensible false magnetic stimulation, of equal localization that other arm, with insufficient intensity, to blind clinical experience.

Device: Magnetic Spinal Stimulation

Interventions

Spinal Magnetic Stimulation (TMS) on Lateral Cord Stimulation (LCS), in the search of the improvement of the tone, motor function and speech, in patients with spastic cerebral Palsy. Due to its non-invasiveness and possible efficacy, the use of Magnetic Spinal Stimulation is proposed to try to prove its therapeutic usefulness. This is the phase 2/3 clinical test of the method, in the future, and as its use could be extended, if the results were positive, its indications could be extended to other pathological conditions, giving a greater spectrum of spastic patients, potentially benefited.

Also known as: Neuromodulation
Sham comparatorTreated Arm: Magnetic Spinal Stimulation plus PKT

Eligibility Criteria

Age16 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 16 years or older.
  • Spastic Cerebral Palsy with stable condition.
  • Motor disability unilateral or predominantly unilateral.
  • Clinically evident speech disorders.
  • Normal or slightly subnormal intellectual coefficient (I.Q 80 or more)
  • Absence of psychiatric disorders

You may not qualify if:

  • Cardiac or severe respiratory disorders.
  • Steady abnormal postures (except possible orthopedic surgical correction)
  • Recurrent chronic bronchial or pulmonary infections.
  • Psychiatric disorders
  • Chronic recurrent urinary infections
  • Severe osteoporosis in affected limbs
  • Chronic skin ulcers
  • Drug addiction.
  • Episodes of Status Epileptucus
  • Personal history, or in close relatives, of medical legal complaint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Rehabilitación San Juan de Dios

Hurlingham, Buenos Aires, 1686, Argentina

RECRUITING

Related Publications (6)

  • Andreani JC, Guma C. Lateral cord stimulation decreases spastic electromyographic spreading: responses in a brain-damaged pig preparation. Neuromodulation. 2008 Jul;11(3):202-7. doi: 10.1111/j.1525-1403.2008.00167.x.

    PMID: 22151097BACKGROUND
  • Abdeen MA, Stuchly MA. Modeling of magnetic field stimulation of bent neurons. IEEE Trans Biomed Eng. 1994 Nov;41(11):1092-5. doi: 10.1109/10.335848.

    PMID: 8001998BACKGROUND
  • Andreani, JCM, Guma C. Lateral Cord Stimulation (LCS) to relieve spasticity experimental protocol and results. Proceedings of the 10th Conference of the International Federation of Electrical Stimulation (IFESS) Montreal-Canada, July 4-8th 2005. pp 153-5.

    BACKGROUND
  • Duchenne de Boulogne. De l'électrisation localisée et de son application à la physiologie, à la pathologie et à la thérapeutique (3e édition). Librairie JB Bailiere et fils. Paris. 1872.

    BACKGROUND
  • Koy A, Pauls KA, Flossdorf P, Becker J, Schonau E, Maarouf M, Liebig T, Fricke O, Fink GR, Timmermann L. Young adults with dyskinetic cerebral palsy improve subjectively on pallidal stimulation, but not in formal dystonia, gait, speech and swallowing testing. Eur Neurol. 2014;72(5-6):340-8. doi: 10.1159/000360984. Epub 2014 Oct 14.

    PMID: 25322688BACKGROUND
  • Lefaucheur JP. Methods of therapeutic cortical stimulation. Neurophysiol Clin. 2009 Feb;39(1):1-14. doi: 10.1016/j.neucli.2008.11.001. Epub 2008 Nov 29.

    PMID: 19268842BACKGROUND

MeSH Terms

Conditions

Cerebral PalsyDysarthriaMuscle Spasticity

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArticulation DisordersSpeech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular Manifestations

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Juan Carlos M Andreani, MD

    CENIT Foundation & Sociedad Argentina de Neuromodulación

    STUDY DIRECTOR
  • Werner Braunsdorf, MD

    Klinik von Magdeburg - Germany

    PRINCIPAL INVESTIGATOR
  • Wojciech Maksymowicz, MD

    University of Warmia and Mazury in Olsztyn- Poland

    PRINCIPAL INVESTIGATOR
  • Tommaso Tufo, MD

    Policlinico A. Gemelli University Hospital Foundation - Rome - Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Juan Carlos M Andreani, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patient and independent evaluator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A comparision, Randomized and double blinded study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 4, 2018

First Posted

September 18, 2018

Study Start

November 18, 2024

Primary Completion

November 1, 2025

Study Completion

March 26, 2026

Last Updated

November 21, 2023

Record last verified: 2023-11

Locations